Bartolome Moya
Bartolome Moya
Balearic Islands Health Research Institute (IdISBa)
Verified email at - Homepage
Cited by
Cited by
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS pathogens 5 (3), e1000353, 2009
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study
G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ...
Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD …
C Juan, B Moyá, JL Pérez, A Oliver
Antimicrobial Agents and Chemotherapy 50 (5), 1780-1787, 2006
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and …
J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ...
International journal of antimicrobial agents 34 (2), 173-176, 2009
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study
AA Ocampo-Sosa, G Cabot, C Rodríguez, E Roman, F Tubau, MD Macia, ...
Antimicrobial agents and chemotherapy 56 (4), 1703-1713, 2012
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa
B Moya, C Juan, S Alberti, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008
Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
B Moyá, L Zamorano, C Juan, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (9), 3933-3937, 2010
Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing
G Cabot, C López-Causapé, AA Ocampo-Sosa, LM Sommer, ...
Antimicrobial agents and chemotherapy 60 (12), 7415-7423, 2016
Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae
K Diestra, C Juan, T Curiao, B Moya, E Miro, J Oteo, TM Coque, ...
Journal of antimicrobial chemotherapy 63 (1), 60-66, 2009
WCK 5107 (zidebactam) and WCK 5153 are novel inhibitors of PBP2 showing potent “β-lactam enhancer” activity against Pseudomonas aeruginosa, including multidrug-resistant …
B Moya, IM Barcelo, S Bhagwat, M Patel, G Bou, KM Papp-Wallace, ...
Antimicrobial agents and chemotherapy 61 (6), e02529-16, 2017
Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection
C Lopez-Causape, E Rojo-Molinero, X Mulet, G Cabot, B Moya, ...
PLoS One 8 (8), e71001, 2013
NagZ Inactivation Prevents and Reverts β-Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa
L Zamorano, TM Reeve, L Deng, C Juan, B Moyá, G Cabot, DJ Vocadlo, ...
Antimicrobial agents and chemotherapy 54 (9), 3557-3563, 2010
Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure
A Ropy, G Cabot, I Sánchez-Diener, C Aguilera, B Moya, JA Ayala, ...
Antimicrobial agents and chemotherapy 59 (7), 3925-3934, 2015
Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth
X Mulet, B Moyá, C Juan, MD Macià, JL Pérez, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 55 (10), 4560-4568, 2011
The system can't perform the operation now. Try again later.
Articles 1–20